Update on pediatric autoimmune encephalitis-associated epilepsy

Key Points

• To improve outcomes for pediatric patients with autoimmune encephalitis-associated epilepsy by identifying key factors.
• Analysis of morbidity associated with pediatric autoimmune encephalitis-associated epilepsy.
• Investigation of risk factors and biomarkers relevant to the condition.
• Development of targeted therapeutic approaches based on findings.
• Identification of significant morbidity rates in affected patients.
• Discovery of potential risk factors and biomarkers that contribute to disease outcomes.